A previous study showed that copper regulates key signaling pathways that underlie PD-L1-mediated immune evasion in cancer; reducing copper levels in tumor cells with copper chelators increases CD8+ T cells and inhibits cancer progression (Voli et al., 2020). The gene discussed is CD8A; the disease is cancer.